References
- International Agency for Research on Cancer (2005). Cervix Cancer Screening. IARC handbooks of cancer prevention, Vol. 10. Lyon: IARCPress. [cited 2018 Apr 15]. Available from: http://www.iarc.fr/en/publications/pdfs-online/prev/handbook10/index.php
- Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer 2013; 49: 3262-73. 10.1016/j.ejca.2013.04.024
- Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-0008
- Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007; 45: 93-106. 10.1016/j.ypmed.2007.06.007
- Sigurdsson K, Hrafnkelsson J, Geirsson G, Gudmundsson J, Salvarsdóttir A. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988. Gynecol Oncol 1991; 43: 64-70.
- Takac I, Ursic-Vrscaj M, Repse-Fokter A, Kodric T, Rakar S, Mozina A, et al. Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia. Eur J Obstet Gynecol Reprod Biol 2008; 140: 82-9. 10.1016/j.ejogrb.2008.02.019
- Landy R, Pesola F, Castañón A, Sasieni P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer 2016; 115: 1140-46. 10.1038/bjc.2016.290
- [National Cervical Cancer Screening Programme ZORA.] [Slovenian]. DP ZORA: Kazalniki. [online] https://zora.onko-i.si/ [Accessed 2018 Mar 29]. Available at: https://zora.onko-i.si/publikacije/kazalniki/
- Elfstrom KM, Arnheim-Dahlstrom L, von Karsa L, Dillner J. Cervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer 2015; 51: 950-68. 10.1016/j.ejca.2015.03.008
- Ivanuš U, Primic Žakelj M. [HPV self-sampling among non-responders to cervical cancer screening programmes: systematic review]. [Slovenian]. Onkologija 2012; 2: 78-86. Available also online (in Slovenian language only): https://www.onko-i.si/fileadmin/onko/datoteke/dokumenti/Onkologija_Letnik_XVI_st_2/7_Onkologija_2_2012_samoodvzem.pdf
- Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 2015; 51: 2375-85. 10.1016/j.ejca.2015.07.006
- Von Karsa L, Arbyn A, De Vuyst H, Dillner J, Dillner L, Franceschi S, et al. (2015). Executive summary. In: European guidelines for quality assurance in cervical cancer screening. Second edition, Supplements. Anttila A, Arbyn A, De Vuyst H, Dillner J, Dillner L, Franceschi S, et al, editors. Luxembourg: Office for Official Publications of the European Union. p. XIII–XXIV. [cited 2018 Apr 10]. Available from: https://publications.europa.eu/en/publication-detail/-/publication/a41a4c40-0626-4556-af5b-2619dd1d5ddc/language-en
- Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172-83. 10.1016/S1470-2045(13)70570-9
- Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al; Self-Sampling Study Working Group. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011; 104: 248-54. 10.1038/sj.bjc.6606040
- Giorgi Rossi P, Fortunato C, Barbarino P, Boveri S, Caroli S, Del Mistro A, et al. HPV Self-sampling Italian Working Group. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter. Br J Cancer 2015; 112: 667-75. 10.1038/bjc.2015.11
- Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd ML, Holtenman M, Milsom I, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2014; 134: 2223-30. https://doi.org/10.1002/ijc.28545
- Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B. Preventing cervical cancer using HPV self-sampling: direct mailing of testkits increases screening participation more than timely opt-in procedures - a randomized controlled trial. BMC Cancer 2018; 18: 273. 10.1186/s12885-018-4165-4
- R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. 2012. ISBN 3-900051-07-0, URL. Available from: http://www.R-project.org/
- Ursic-Vrscaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger I, et al. [Guidelines for management of women with cervical precancerous lesions]. [Slovenian] In: Ursic-Vrscaj M, editor. Ljubljana: Institute of Oncology Ljubljana; 2011. [cited 2018 Mar 15]. Available at (in Slovene language only): https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/2011_Smernice_web.pdf
- Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505-10. 10.1002/ijc.22484
- Wikström I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011; 105: 337-9. 10.1038/bjc.2011.236
- Sanner K, Wikström I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009; 101: 871-4. 10.1038/sj.bjc.6605194
- Lam JU, Rebolj M, Møller Ejegod D, Pedersen H, Rygaard C, Lynge E, et al. Human papillomavirus self-sampling for screening nonattenders: opt-in pilot implementation with electronic communication platforms. Int J Cancer 2017; 140: 2212-19. 10.1002/ijc.30647
- Cadman L, Wilkes S, Mansour D, Austin J, Ashdown-Barr L, Edwards R, et al. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. J Med Screen 2015; 22: 28-37. 10.1177/0969141314558785
- Kitchener H, Gittins M, Cruickshank M, Moseley C, Fletcher S, Albrow R, et al. A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial. J Med Screen 2017. 10.1177/0969141317696518 [Epub ahead of print]
- Dugué PA, Lynge E, Rebolj M. Mortality of non-participants in cervical screening: Register-based cohort study. Int J Cancer 2014; 134: 2674-82. 10.1002/ijc.28586
- Učakar V, Poljak M, Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 2012; 30: 116-20. 10.1016/j.vaccine.2011.10.066
- Enerly E, Bonde J, Schee K, Pedersen H, Lönnberg S, Nygård M. Self-Sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian Cervical Cancer Screening Programme. PLoS One 2016; 11: e0151978. 10.1371/journal.pone.0151978
- Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer 2012; 130: 1128-35. 10.1002/ijc.26128
- Gök M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: c1040. 10.1136/bmj.c1040. Erratum in: BMJ 2016; 353: i2823.
- Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 2007; 197: 356.e1-6. 10.1016/j.ajog.2007.07.049